These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
469 related articles for article (PubMed ID: 27578850)
41. Naturally Acquired Human Antibodies Against Reticulocyte-Binding Domains of Plasmodium vivax Proteins, PvRBP2c and PvRBP1a, Exhibit Binding-Inhibitory Activity. Gupta ED; Anand G; Singh H; Chaddha K; Bharti PK; Singh N; Sharma YD; Gaur D J Infect Dis; 2017 May; 215(10):1558-1568. PubMed ID: 28379500 [TBL] [Abstract][Full Text] [Related]
42. Cytokine gene polymorphisms are not associated with anti-PvDBP, anti-PvAMA-1 or anti-PvMSP-119 IgG antibody levels in a malaria-endemic area of the Brazilian Amazon. Furini AA; Capobianco MP; Storti-Melo LM; Cunha MG; Cassiano GC; Machado RL Malar J; 2016 Jul; 15(1):374. PubMed ID: 27435973 [TBL] [Abstract][Full Text] [Related]
43. Malaria transmission and individual variability of the naturally acquired IgG antibody against the Plasmodium vivax blood-stage antigen in an endemic area in Brazil. Costa EMF; Amador ECC; Silva ES; Alvarenga CO; Pereira PE; Póvoa MM; Cunha MG Acta Trop; 2020 Sep; 209():105537. PubMed ID: 32454033 [TBL] [Abstract][Full Text] [Related]
44. Antibody response to Plasmodium vivax antigens in Fy-negative individuals from the Colombian Pacific coast. Herrera S; Gómez A; Vera O; Vergara J; Valderrama-Aguirre A; Maestre A; Méndez F; Wang R; Chitnis CE; Yazdani SS; Arévalo-Herrera M Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):44-9. PubMed ID: 16291766 [TBL] [Abstract][Full Text] [Related]
45. Evaluation of immune responses elicited in mice against a recombinant malaria vaccine based on Plasmodium vivax Duffy binding protein. Yazdani SS; Shakri AR; Mukherjee P; Baniwal SK; Chitnis CE Vaccine; 2004 Sep; 22(27-28):3727-37. PubMed ID: 15315853 [TBL] [Abstract][Full Text] [Related]
46. Antigenic polymorphism and naturally acquired antibodies to Plasmodium vivax merozoite surface protein 1 in rural Amazonians. Bastos MS; da Silva-Nunes M; Malafronte RS; Hoffmann EH; Wunderlich G; Moraes SL; Ferreira MU Clin Vaccine Immunol; 2007 Oct; 14(10):1249-59. PubMed ID: 17699838 [TBL] [Abstract][Full Text] [Related]
48. Evaluation of the antigenicity of universal epitopes from PvDBPII in individuals exposed to Plasmodium vivax malaria. Martinez P; Lopez C; Saravia C; Vanegas M; Patarroyo MA Microbes Infect; 2010 Dec; 12(14-15):1188-97. PubMed ID: 20804855 [TBL] [Abstract][Full Text] [Related]
49. Structural basis for neutralization of Plasmodium vivax by naturally acquired human antibodies that target DBP. Urusova D; Carias L; Huang Y; Nicolete VC; Popovici J; Roesch C; Salinas ND; Dechavanne S; Witkowski B; Ferreira MU; Adams JH; Gross ML; King CL; Tolia NH Nat Microbiol; 2019 Sep; 4(9):1486-1496. PubMed ID: 31133752 [TBL] [Abstract][Full Text] [Related]
50. Immunoglobulin GM 3 23 5,13,14 phenotype is strongly associated with IgG1 antibody responses to Plasmodium vivax vaccine candidate antigens PvMSP1-19 and PvAMA-1. Pandey JP; Morais CG; Fontes CJ; Braga EM Malar J; 2010 Aug; 9():229. PubMed ID: 20696056 [TBL] [Abstract][Full Text] [Related]
54. The acquisition of long-lived memory B cell responses to merozoite surface protein-8 in individuals with Plasmodium vivax infection. Kochayoo P; Kittisenachai N; Changrob S; Wangriatisak K; Muh F; Chootong P; Han ET Malar J; 2019 May; 18(1):188. PubMed ID: 31151441 [TBL] [Abstract][Full Text] [Related]
55. Characterization of inhibitory anti-Duffy binding protein II immunity: approach to Plasmodium vivax vaccine development in Thailand. Chootong P; Panichakul T; Permmongkol C; Barnes SJ; Udomsangpetch R; Adams JH PLoS One; 2012; 7(4):e35769. PubMed ID: 22558221 [TBL] [Abstract][Full Text] [Related]
56. The Blood Stage Antigen RBP2-P1 of Plasmodium vivax Binds Reticulocytes and Is a Target of Naturally Acquired Immunity. Chim-Ong A; Surit T; Chainarin S; Roobsoong W; Sattabongkot J; Cui L; Nguitragool W Infect Immun; 2020 Mar; 88(4):. PubMed ID: 32014895 [TBL] [Abstract][Full Text] [Related]
57. Natural immune response to Plasmodium vivax alpha-helical coiled coil protein motifs and its association with the risk of P. vivax malaria. Céspedes N; Li Wai Suen CSN; Koepfli C; França CT; Felger I; Nebie I; Arévalo-Herrera M; Mueller I; Corradin G; Herrera S PLoS One; 2017; 12(6):e0179863. PubMed ID: 28651021 [TBL] [Abstract][Full Text] [Related]
58. Immunogenicity of a synthetic vaccine based on Plasmodium vivax Duffy binding protein region II. Ntumngia FB; Barnes SJ; McHenry AM; George MT; Schloegel J; Adams JH Clin Vaccine Immunol; 2014 Sep; 21(9):1215-23. PubMed ID: 24964808 [TBL] [Abstract][Full Text] [Related]
59. Plasmodium vivax VIR Proteins Are Targets of Naturally-Acquired Antibody and T Cell Immune Responses to Malaria in Pregnant Women. Requena P; Rui E; Padilla N; Martínez-Espinosa FE; Castellanos ME; Bôtto-Menezes C; Malheiro A; Arévalo-Herrera M; Kochar S; Kochar SK; Kochar DK; Umbers AJ; Ome-Kaius M; Wangnapi R; Hans D; Menegon M; Mateo F; Sanz S; Desai M; Mayor A; Chitnis CC; Bardají A; Mueller I; Rogerson S; Severini C; Fernández-Becerra C; Menéndez C; Del Portillo H; Dobaño C PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005009. PubMed ID: 27711158 [TBL] [Abstract][Full Text] [Related]
60. Finding the sweet spots of inhibition: understanding the targets of a functional antibody against Plasmodium vivax Duffy binding protein. Ntumngia FB; King CL; Adams JH Int J Parasitol; 2012 Nov; 42(12):1055-62. PubMed ID: 23068913 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]